Use of "Novolep", a by-product of D.D.S., for the treatment of trophic ulcers (planter) in leprosy.
D000328:Adult; D003622:Dapsone / Q000627:therapeutic use*; D004338:Drug Combinations; D005260:Female; D005533:Foot Dermatoses / Q000188:drug therapy*; D006801:Humans; D007501:Iron; D007871:Leg Ulcer / Q000188:drug therapy*; D007917:Leprostatic Agents / Q000627:therapeutic use*; D007918:Leprosy / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D013450:Sulfones / Q000627:therapeutic use*
D004338:Drug Combinations; D007917:Leprostatic Agents; D013450:Sulfones; C014136:Novolep; D003622:Dapsone; D007501:Iron